Group 1 - All newly listed stocks in the Hong Kong market this year have seen an increase on their first trading day, with no stocks experiencing a decline [2] - Guoen Technology (02768.HK) officially listed on the Hong Kong Stock Exchange on February 4, with a significant opening increase of 27%, reaching a price of HKD 45.72 [2] - The public offering of Guoen Technology was oversubscribed by 2,251.85 times, with 3 million shares available for public subscription, accounting for 10% of the total offering [3] Group 2 - The international placement of Guoen Technology was oversubscribed by 10.03 times, with 27 million shares allocated, representing 90% of the total offering [3] - The final offer price for Guoen Technology was set at HKD 36.00 per share, which is in the lower-middle range of the pricing range (HKD 34.00 to HKD 42.00), raising approximately HKD 1 billion in net proceeds [3] - Guoen Technology specializes in chemical new materials and collagen products, serving the chemical and health industries, focusing on R&D, production, and sales [4] Group 3 - Guoen Technology operates within the large chemical industry, covering the entire value chain of chemical new materials, including upstream green petrochemical materials and downstream applications in electronics, automotive, and renewable energy sectors [4] - The company has a complete layout from collagen and derivative raw materials to end products, gradually becoming a comprehensive group in the health sector [4] - For the fiscal years 2022 to 2025, Guoen Technology's revenues are projected to be RMB 13.406 billion, RMB 17.439 billion, RMB 19.188 billion, and RMB 17.444 billion, with corresponding profits of RMB 0.724 billion, RMB 0.540 billion, RMB 0.721 billion, and RMB 0.721 billion [4]

Core Insights - The report highlights a mixed performance in the Hong Kong stock market, with the Hang Seng Index rising by 0.51% while the Hang Seng Tech Index fell by 1% [2] - The paper discusses the significant rebound in the real estate sector, with notable increases in stock prices for several property companies, attributed to a more lenient regulatory environment [3] - The consumer sector also showed positive movements, particularly in the sports and beverage segments, indicating a shift in investor sentiment towards traditional sectors amid tech stock volatility [4] Company Overview - The specific company under review, Guo'en Technology (2768.HK), specializes in chemical new materials and gelatin, with a strong focus on organic polymer modified materials and organic polymer composite materials [7] - The company is projected to be the second-largest player in China's organic polymer modified materials market by sales revenue in 2024, holding a market share of 2.5% [7] - Revenue growth is expected to be steady, with total revenues forecasted at approximately RMB 134.1 billion, RMB 174.4 billion, and RMB 191.9 billion for the years 2022, 2023, and 2024 respectively [7] Industry Status and Outlook - The global market for organic polymer modified materials and organic polymer composite materials is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2029, with China's growth rate projected at 14.1% [8] - The largest application for these materials is in the home appliance sector, accounting for 38.2% of usage, followed by the automotive industry at 17.9% [8] Advantages and Opportunities - The company benefits from a vertically integrated model that strengthens its market position in the organic polymer modified materials sector [9] - Strategic expansion into the health sector is part of a dual growth engine strategy, enhancing the company's growth potential [9] - The company has established long-term partnerships with leading enterprises, supported by a strong reputation and innovative capabilities [9] Fundraising Purpose - Approximately 50% of the funds raised (around HKD 528.5 million) will be allocated to establishing a new production base in Thailand to expand capacity [11] - About 35% (around HKD 370.5 million) will be used to enhance the production capacity of the existing facility in Yixing, China [11] - The remaining funds will support operational expenses and general corporate purposes [11] Investment Recommendations - The company ranks second in the organic polymer modified materials sector in China and is the largest producer of polystyrene by capacity [13] - The projected growth in net profit for the first ten months of 2025 is 40% year-on-year, indicating strong financial performance [13] - Despite competitive pressures and potential fluctuations in raw material prices, the company presents a compelling investment opportunity with a significant discount in its valuation compared to its A-share counterpart [13]

Investment Rating - The investment rating for the company is 5.5 out of 10, based on operational performance, industry outlook, valuation, and market sentiment [8]. Core Insights - The company is a leading supplier in China focused on chemical new materials and gelatin, with over 95% of its revenue coming from the large chemical sector. It ranks as the second-largest in organic polymer modified materials and organic polymer composite materials in China, holding a market share of 2.5% [1]. - The company has shown steady revenue growth, with projected revenues of approximately RMB 134.1 billion, 174.4 billion, and 191.9 billion for the years 2022, 2023, and 2024 respectively. In the first ten months of 2025, revenue reached RMB 174.4 billion, reflecting a year-on-year increase of 10% [1]. - The net profit attributable to shareholders for 2022, 2023, and 2024 was RMB 6.63 billion, 4.71 billion, and 6.85 billion respectively, with a significant increase of 40% year-on-year to RMB 7.12 billion in the first ten months of 2025 [1]. Company Overview - The company specializes in green petrochemical materials, including aromatic olefins, styrene, polystyrene, and organic polymer modified materials, which are applied in automotive, new energy, and home appliance sectors. It also operates in the health sector, producing gelatin, collagen, and hollow capsules [1]. - The global market for organic polymer modified materials and organic polymer composite materials is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2029, with China projected to grow at 14.1% [2]. Advantages and Opportunities - The company has established a strong market position in the organic polymer modified materials sector through a vertically integrated model and strategic expansion into the health sector, creating a dual growth engine under its "one body, two wings" strategy [3]. - It has a robust research and development capability, a strong reputation, and long-term partnerships with leading enterprises, supported by a visionary and experienced management team [3].

Core Viewpoint - Guoen Technology (02768.HK) plans to globally offer 30 million H-shares, with 3 million shares available in Hong Kong and 27 million shares for international distribution, aiming for a price range of HKD 34.00 to 42.00 per share, with trading expected to commence on February 4, 2026 [2][3] Company Overview - Guoen Technology specializes in chemical new materials and gelatin, collagen, and related products, serving both the chemical and health industries [3] - The company operates in two main sectors: the large chemical sector, providing solutions to manufacturers in automotive, new energy, and home appliances, and the health sector, supplying raw materials for supplements and pharmaceuticals [3][4] Market Position - In the large chemical industry, Guoen is the second-largest company in China for organic polymer modified materials and organic polymer composite materials, holding a market share of 2.5% as of 2024 [4] - Guoen is also the largest producer of polystyrene in China by production capacity as of 2024 [4] Financial Performance - The company has shown strong revenue growth, with revenues of RMB 13.406 billion, RMB 17.439 billion, and RMB 19.188 billion for the fiscal years 2022, 2023, and 2024 respectively, reflecting a compound annual growth rate (CAGR) of 19.6% from 2022 to 2024 [7] - The sales figures for the fiscal years 2023 and 2024 indicate year-on-year growth rates of 30.1% and 10.0%, respectively [7] Market Trends - The market for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion by 2024, with a CAGR of 15.7% [8] - The market is expected to continue strong growth, reaching RMB 1,037.5 billion by 2029, with a forecasted CAGR of 14.1% from 2025 to 2029 [8] Use of Proceeds - The net proceeds from the share offering are estimated at approximately HKD 1.057 billion, with plans to allocate 50% for establishing a new production base in Thailand, 35% for expanding capacity in Yixing, and 10% for investments in Hong Kong [9]

Group 1 - The core viewpoint of the news is that Guoen Technology (国恩科技) is preparing for its IPO in the Hong Kong market, with a strong foundation and significant fundraising expectations [2][4] - Guoen Technology plans to globally issue approximately 30 million H-shares, with 3 million shares allocated for public offering in Hong Kong and 27 million shares for international offering [2] - The expected net fundraising amount is approximately HKD 1.058 billion, with funds allocated for expanding production capacity in Thailand and China, as well as for operational purposes [2][4] Group 2 - Guoen Technology specializes in new chemical materials and collagen products, serving the chemical and health industries, focusing on R&D, production, and sales [4] - The company ranks second in the organic polymer modification and composite materials industry in China by sales revenue, with a market share of 2.5%, and is the largest producer of polystyrene in China [4] - In the health sector, Guoen Technology's subsidiary, Dongbao Biological, has established a complete layout from collagen raw materials to end products, becoming a comprehensive group in the health segment [4] Group 3 - For the fiscal years 2022 to 2024, Guoen Technology's revenues were RMB 13.406 billion, RMB 17.439 billion, and RMB 19.188 billion, with corresponding profits of RMB 0.724 billion, RMB 0.540 billion, and RMB 0.721 billion [5] - The company has shown solid performance in its financial results, indicating a stable growth trajectory [5]

Core Viewpoint - Qingdao Guoen Technology Co., Ltd. is preparing for its listing on the Hong Kong Stock Exchange, focusing on new chemical materials and gelatin, with a strong emphasis on both the chemical and health industries [1]. Group 1: Company Overview - Guoen Technology specializes in the research, production, and sales of products for the chemical and health industries, serving clients in sectors such as automotive, renewable energy, and healthcare [3]. - The company is recognized as the second-largest producer of organic polymer modified materials and organic polymer composite materials in China, holding a market share of 2.5% as of 2024 [4]. Group 2: Product and Market Position - In the chemical sector, Guoen's product range includes upstream green petrochemical materials and midstream organic polymer modified materials, catering to diverse applications in electronics, automotive, and energy storage [4]. - In the health sector, the company focuses on the natural collagen industry, with its subsidiary Dongbao Bio leveraging a vertically integrated strategy to cover the entire value chain from collagen to end products [5]. Group 3: Financial Performance - The company's revenue for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 were approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion, respectively [6]. - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [6].

Group 1: Company Overview - Qingdao Guoen Technology Co., Ltd. (002768.SZ) is focused on new chemical materials and gelatin, collagen upstream and downstream products, and has passed the listing hearing on the Hong Kong Stock Exchange [1] - The company serves the chemical and health industries, primarily engaged in the R&D, production, and sales of products for industrial and commercial use [3] Group 2: Industry Position - In the chemical industry, Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials, with a market share of 2.5% as of 2024 [4] - The company is also the largest producer of polystyrene in China by production capacity as of 2024 [4] Group 3: Product and Market Focus - Guoen Technology focuses on the natural collagen industry, with a vertical integration strategy that covers collagen peptide derivatives to end products [5] - The company is the second-largest producer of bone gelatin in China and the second-largest domestic brand in the hollow capsule production industry as of 2024 [6] Group 4: Market Growth - The market size for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion in 2024, with a compound annual growth rate (CAGR) of 15.7% [6] - The market is expected to continue growing at a CAGR of 14.1% from 2025 to 2029, reaching RMB 1,037.5 billion by 2029 [6] Group 5: Financial Performance - Guoen Technology's revenues for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 were approximately RMB 13.41 billion, RMB 17.44 billion, RMB 19.19 billion, and RMB 17.44 billion respectively [6][7] - The company reported net profits of RMB 724 million, RMB 540 million, RMB 721 million, and RMB 721 million for the same periods [6][8]

Company Overview - Guoen Technology is a Chinese supplier focused on new chemical materials and gelatin, collagen upstream and downstream products, serving the chemical and health industries [4] - The company engages in research, production, and sales of products for industrial and commercial use, with clients including manufacturers in automotive, new energy, and home appliances [4] - In the health sector, Guoen Technology's clients include medical and pharmaceutical manufacturers who use its products as raw materials for supplements and medications [4] Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% in 2024 [5] - The company is the largest polystyrene producer in China by production capacity in 2024 [5] - In the health sector, Guoen Technology is the second-largest bone gelatin producer in China by output and the largest domestic brand in the same category [5] Financial Performance - The company reported revenues of approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion for the fiscal years 2022, 2023, 2024, and the first ten months of 2025, respectively [6] - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [7] - The return on equity for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 was 12.3%, 8.5%, 10.2%, and 9.5%, respectively [10] Industry Overview - The global polymer materials market is projected to grow from RMB 298.9 billion in 2020 to RMB 456.15 billion in 2024, with a compound annual growth rate (CAGR) of 11.1% [12] - China's polymer materials market is expected to expand from RMB 110.8 billion in 2020 to RMB 162.8 billion in 2024, with a CAGR of 10.1% [12] - The organic polymer modified materials and organic polymer composite materials market is anticipated to grow from RMB 84.81 billion in 2020 to RMB 150.38 billion in 2024, with a CAGR of 15.4% [14]